TABLE I.
Transplant
|
Diagnosis of PTLD
|
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Age and sex | Organ | Immu. supp | After Tx | After PTLD | Disease type | Location | EBV status | Clonality assay | Refs. | |
1 | 4 M/f | Lung | Tac, Pred | 3 Y | 15 M-A | PTL (CD4+) | GI, blood, lung | Neg | FCM+PCR | Yang |
2 | 4 Y/f | Liver | Tac | 5 Y | 5 M-A | PTL (CD4+) | GI, liver, BM, CSF | Neg | FCM+PCR | Yang |
3 | 5 Y/f | Multi-organ | Tac, cellcept Pred | 2 Y | 5 M-A | PTL (CD3+) | Graft-GI | Neg | SB | [14] |
4 | 1 Y/m | Liver | CsA, Pred | 3 M | 1 M | Polymorphous | Brain | Neg | MNR | [15] |
5 | 4 Y/m | Liver | Tac | 6 Y | 12 M-A | PTL (CD8+) | GI, UR, spleen, brain, pleura | Pos. | PCR | [16] |
6 | 9 D/f | Heart | CsA, Aza | 5 Y | 2 M | HSGD | BM, liver | Neg | SB+PCR | [17] |
7 | 15 Y/m | Heart | CsA, Aza, Pred, ATG | 4 M | 3 M | PTL (CD8+) AILD-like? | Blood | Pos | SB | [18] |
8 | 15 Y/f | Liver | Tac, Pred | 4 Y | 17 M-A | PTL (CD4+) | GI | Pos | PCR | [19] |
9 | 1 M/m | Heart | NR | 14 Y | NR | ALCL | Neck LNs | Pos | PCR | [20] |
10 | 12 Y/m | Kidney | Aza, Pred | 10 Y | Living | LBL | NR | Neg | SB | [21] |
11 | 14 Y/m | Kidney | Aza, Pred | 11 Y | 5 M | Diffuse large cell | Renograft, CSF | Neg | SB | [21] |
12 | 5 Y/m | Heart | CsA, Aza, Pred | 6 Y | Days | PTL (CD43) | Spleen | Pos | SB | [5] |
13 | 4 Y/f | Kidenys | CsA, siroli | 2 Y (4Y) | 1 Y (3Y) | B-PTLD (node) T-PTLD (liver, BM) | Liver, BM, LNs | Pos | PCR | [22] |
14 | 14 Y/f | Kidney | CsA | 28 Y | 1 4D | Agg. LGL-like CD8+ | BM | Neg | SB | [4] |
m, male; f, female; Y, years; M, months; D, days; LNs, lymph nodes; Tx, transplant; CsA, cyclosporine A; Aza, azathioprine; Pred, prednisone; Tac, tacrolimus; Cellcept, mycophenolate mofetil; MTX, methotrexate; Siroli, sirolimus; -A, alive; NR, not reported; HSGD, hepatosplenic gamma/delta lymphoma; LBL, lymphoblastic lymphoma; FCM, flow cytometry; SB, Southern blot; PCR, polymerase chain reaction; MNR, method not reported.